期刊文献+

乙型肝炎病毒前S1抗原在核苷类药物抗病毒治疗上的意义

Significance of Pre-S1 antigen detection in evaluation of antiviral therapy by nucleotide analogs
原文传递
导出
摘要 目的研究HBV前S1抗原(Pre-S1)在指导核苷(酸)类药物抗病毒治疗上的意义。方法将HBe舷阳性患者经拉米夫定治疗获得完全应答并维持疗效6个月以上停药者以Pre-S1是否阳性分成两组,比较两组的远期疗效。结果Pre-S1阴性组一年、二年远期持续应答率分别为80%、21.05%,差异有统计学意义(P〈0.01)。阳性组患者一年、二年远期持续应答率分别为65%、10.53%,差异有统计学意义(P〈0.01)。结论检测Pre-S1可作为判断慢性乙型肝炎患者经核苷(酸)类药物治疗完全应答后远期疗效和预后的重要指标。 Objective To evaluate the significance of HBV Pre-S1 antigen detection in clinical evaluation of antiviral therapy by nucleotide analogs. Method HBeAg positive patients which had combined complete response and sustained for 6 months after lamivudine therapy were divided into two groups according Pre-S1 detection and their therapeutic effect was compared. Results The response rates of one year and two year of HBV Pre-S1 antigen positive and negative were 80% and 21.05% respectively, and showed statistical difference( P 〈0.01). The response rates of one year and two year of HBV Pre-S1 antigen negative were 65% and 10.53% respectively, and showed statistical difference( P 〈 0.01 ). Conclusions The detection of HBV Pre-S1 antigen may become an index that judges long-term effect of chronic hepatitis patients after nucleotide analogs therapy.
出处 《国际流行病学传染病学杂志》 CAS 2008年第2期101-102,110,共3页 International Journal of Epidemiology and Infectious Disease
关键词 肝炎病毒 乙型 核苷类药物 疗效 Hepatitis B virus Nucleotide analog Prognosis
  • 相关文献

参考文献3

二级参考文献17

  • 1Kuijpers L, Koens M, Lain MD, et al. Pre-S proteins in hepatitis B.J Med Virol, 1989, 28: 47.
  • 2Petit MA, Zoulim F, Capel F, et al. Variable expression of Pre-S1antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication. Hepatology,1990, 11: 809-814.
  • 3Yuki N, Hayashi N, Katayama K, et al. Quantitative analysis of PreS1 and Pre-S2 in relation to HBsAg expression. Hepatology, 1990,11: 38.
  • 4Pichoud C, Berby F, Stuyver L, et al. Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B. J Hepatol, 2000, 32: 307-316.
  • 5Haruna Y, Hayashi N, Yuki N, et al. PreS1 and PreS2 antigen as prognostic indexes for interferon treatment in patient with chronic hepatitis B. Scand J Gastroenterol, 1992, 27: 615-619.
  • 6Neurath AR,Seto B,Strick N.Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protiein are virus nentralizing and protective[J].Vaccine,1989,7(3):234-236.
  • 7Petit MA,Capel F,Zoulim F,et al.PreS antigen expression and anti -preS res ponse in hepatitis B virus infections:relationship to serum HBV-DNA.intahepatic HbcAg,liver da mage and dpecific T cell re-sponse[J].Arch Virol Suppl,1992,4:105-112.
  • 8张定风,主编.乙型肝炎的发病机理及临床.第一版.重庆:重庆出版社,1992,123.
  • 9Tiollais P,et al.Structure,genetic organization and transcription of hepadna viruses.In:Zuckerman AS.Eds.Virus hepatitis and Liver disease New York:Alan R liss liss Inc N.Y,1998,295 -300.
  • 10Ibarra MZ,Mora I,Bartolome J,et al.Detection of proteins encoded by the pre-S region of hepatitis B virus in the sera of HBsAg carriers:relation to viral replication[J].Liver,1989,9(3):153-158.

共引文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部